mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.07 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.07 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.07 |